Antibody Injection Cuts Severe COVID-19 Risk: AstraZeneca Study
An antibody combination treatment delivered through an injection has shown "statistically significant" reduction in severe Covid or death compared to placebo in non-hospitalised patients with mild-to-moderate symptomatic Covid, AstraZeneca reported